Ly et al., 2011 - Google Patents
Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity?Ly et al., 2011
View HTML- Document ID
- 8931110964634341301
- Author
- Ly N
- Litonjua A
- Gold D
- Celedón J
- Publication year
- Publication venue
- Journal of Allergy and Clinical Immunology
External Links
Snippet
Current evidence supports a role for gut colonization in promoting and maintaining a balanced immune response in early life. An altered or less diverse gut microbiota composition has been associated with atopic diseases, obesity, or both. Moreover, certain …
- 210000001035 Gastrointestinal Tract 0 title abstract description 103
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2220/00—Lactobacillus
- A23Y2220/73—Rhamnosus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ly et al. | Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? | |
| Perdijk et al. | Sialyllactose and galactooligosaccharides promote epithelial barrier functioning and distinctly modulate microbiota composition and short chain fatty acid production in vitro | |
| Park et al. | Imbalance of gut Streptococcus, Clostridium, and Akkermansia determines the natural course of atopic dermatitis in infant | |
| Shadid et al. | Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study | |
| Collado et al. | Microbial ecology and host-microbiota interactions during early life stages | |
| Niers et al. | The effects of selected probiotic strains on the development of eczema (the PandA study) | |
| Zuccotti et al. | Probiotics for prevention of atopic diseases in infants: systematic review and meta‐analysis | |
| Li et al. | Early development of the gut microbiome and immune-mediated childhood disorders | |
| Fujimura et al. | Role of the gut microbiota in defining human health | |
| Wang et al. | Children with atopic dermatitis show clinical improvement after Lactobacillus exposure | |
| Power et al. | Intestinal microbiota, diet and health | |
| Sanz et al. | Understanding the role of gut microbes and probiotics in obesity: how far are we? | |
| Kozyrskyj et al. | Fetal programming of overweight through the microbiome: boys are disproportionately affected | |
| Hojsak et al. | Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial | |
| Taylor et al. | Effects of probiotic supplementation for the first 6 months of life on allergen‐and vaccine‐specific immune responses | |
| Rougé et al. | Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial | |
| Huurre et al. | Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double‐blind placebo‐controlled study | |
| West et al. | Probiotics during weaning reduce the incidence of eczema | |
| Abrahamsson et al. | Gut microbiota and allergy: the importance of the pregnancy period | |
| Dotterud et al. | Probiotics in pregnant women to prevent allergic disease: a randomized, double‐blind trial | |
| Holscher et al. | Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula‐fed infants: a randomized, double‐blind, controlled trial | |
| Million et al. | Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals | |
| Canani et al. | The role of the commensal microbiota in the regulation of tolerance to dietary allergens | |
| Boyle et al. | Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial | |
| Prescott et al. | Early markers of allergic disease in a primary prevention study using probiotics: 2.5‐year follow‐up phase |